![]() |
市场调查报告书
商品编码
1917963
饲料酵母市场-2026-2031年预测Feed Yeast Market - Forecast from 2026 to 2031 |
||||||
预计饲料酵母市场将从 2025 年的 17.81 亿美元成长到 2031 年的 23.23 亿美元,复合年增长率为 4.53%。
饲料酵母(主要为活的或灭活的酿酒酵母,以及一些特殊菌株,例如假丝酵母(Torula)和弯孢酵母属)已成为现代单胃动物和反刍动物营养中不可或缺的功能性添加剂。活性干酵母、酵母培养物、水解酵母和富硒衍生物在牛发挥多种作用机制:透过清除氧气稳定瘤胃pH值;优先刺激纤维素分解菌;提高纤维消化率;降低亚急性瘤胃酸中毒(SARA)的风险;改善挥发性脂肪酸组成;并透过甘露聚醣和β-葡聚醣组织发挥直接的益生元作用,这些物质能够捕获肠道相关物质。
在禽类和猪的养殖中,酵母组成总是能提高饲料转换率2-5%,增加绒毛高度与隐窝深度的比值,并显着降低沙门氏菌和大肠桿菌的定植。富含核苷酸和麸胺酸的水解酵母产品越来越多地被添加到断奶仔猪饲料和早期肉鸡生长日粮中,以促进肠道成熟并缓解生长抑制,作为抗生素生长促进剂的替代品。目前,大多数主要市场已禁用抗生素生长促进剂。
结构性成长要素维持不变,全球肉类和蛋类需求持续上升。人均家禽消费量仍远低于饱和水平,尤其是在亚太地区。饲料抗生素的逐步淘汰造成了永久性的市场空白,而酵母基解决方案正以经济高效的方式填补这一空白。此外,水产养殖和宠物食品领域蛋白质结构的转变,推动了对适口偏好好、具有免疫调节作用且不含海洋过敏原成分的需求。
亚太地区已巩固其作为全球最大生产国和消费国的地位。中国、越南、泰国和印度拥有大规模的家禽和生猪一体化生产能力,并积极推动酪农和牛育肥场的现代化改造。本地酵母发酵能力(通常与乙醇、柠檬酸和啤酒厂相结合)使其在交付上与进口特殊添加剂竞争。北美在创新和高规格产品(有机硒酵母、富含核苷酸的水解物)方面保持主导地位,同时受益于一个由营养学家组成的成熟网络,他们积极采用基于实证的功能性饲料。
家禽在产量和产值方面仍然是领先的养殖品种。肉鸡和蛋鸡对添加0.5-2公斤/吨的活性酵母和酵母培养物有明显的反应。商业性田间试验通常显示,饲料转换率(FCR)提高3-6个百分点,在热压力和高密度饲养条件下存活率提高1-2%。蛋鸡生产商越来越多地指定使用酵母衍生的成分,以改善无抗生素和放养系统中蛋壳品质和蛋黄稳定性。
商业产品系列已趋于成熟,并分为四个不同的类别:
成本效益计算通常显示,在商业条件下,投资回报率为 3:1 至 8:1,这使得酵母成为后抗生素时代最具经济吸引力的选择之一。
总之,饲料酵母已从一种小众添加剂发展成为家禽、猪和乳牛高性能饲料中的标准成分。其多方面的益处——瘤胃稳定、病原体控制、免疫调节和提高营养物质生物利用度——与业界在提高生产力、永续性和无抗生素认证方面的三重目标完美契合。拥有大规模、低成本发酵设施和菌株特异性功效数据的公司将继续在该领域保持主导,儘管商业化压力日益增大,但技术差异化仍能带来显着价值。
它是用来做什么的?
产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响
Feed Yeast Market is projected to expand at a 4.53% CAGR, attaining USD 2.323 billion in 2031 from USD 1.781 billion in 2025.
Feed yeast-predominantly live or inactivated Saccharomyces cerevisiae, along with specialty strains such as Candida utilis (torula) and Kluyveromyces spp.-has become a cornerstone functional additive in modern monogastric and ruminant nutrition. Active dry yeast, yeast culture, hydrolyzed yeast, and selenium-enriched derivatives deliver multiple modes of action: stabilization of rumen pH through oxygen scavenging and preferential stimulation of cellulolytic bacteria in cattle, enhanced fiber digestibility, reduced risk of sub-acute ruminal acidosis (SARA), improved volatile fatty acid profiles, and direct prebiotic effects via mannans and B-glucans that bind enteric pathogens and modulate gut-associated lymphoid tissue.
In poultry and swine, yeast fractions consistently demonstrate 2-5 % improvements in feed conversion ratio, increased villus height:crypt depth ratios, and measurable reductions in Salmonella and E. coli colonization. Hydrolyzed yeast products rich in nucleotides and glutamic acid are increasingly specified in post-weaning piglet diets and early broiler starter phases to accelerate gut maturation and mitigate the growth check previously managed by antibiotic growth promoters now banned in most major markets.
The structural growth drivers remain unchanged: global meat and egg demand continues its upward trajectory, particularly in Asia-Pacific where per-capita poultry consumption is still far below saturation levels; regulatory phase-out of in-feed antibiotics has created a permanent void that yeast-based solutions fill cost-effectively; and the protein transition in aquaculture and pet food is elevating demand for palatable, immune-modulating ingredients that do not carry marine-allergen risk.
Asia-Pacific has solidified its position as both the largest production and consumption region. China, Vietnam, Thailand, and India combine massive poultry and swine integrator capacity with aggressive modernization of dairy and beef feedlots. Local yeast fermentation capacity-often co-located with ethanol, citric acid, or brewery plants-keeps delivered cost competitive against imported specialty additives. North America maintains leadership in innovation and high-specification products (organic selenium yeast, nucleotide-enriched hydrolysates) while benefiting from sophisticated nutritionist networks that readily adopt evidence-based functional feeds.
Poultry remains the dominant species segment by volume and value. Broilers and layers respond predictably to live yeast and yeast culture inclusion at 0.5-2 kg/t, with commercial field trials routinely reporting 3-6 points FCR improvement and 1-2 % livability gains under heat-stress or high-density conditions. Egg producers increasingly specify yeast derivatives for shell quality and yolk color stability in antibiotic-free and cage-free systems.
Commercial portfolios have matured into four distinct categories:
Cost-of-gain calculations typically show payback ratios of 3:1 to 8:1 under commercial conditions, making yeast one of the most economically attractive alternatives in the post-AGP era.
In conclusion, feed yeast has transitioned from niche additive to standard inclusion in high-performance rations across poultry, swine, and dairy. Its multifaceted benefits-rumen stabilization, pathogen control, immune modulation, and nutrient bioavailability-align perfectly with the industry's simultaneous pursuit of productivity, sustainability, and antibiotic-free certification. Companies controlling large-scale, low-cost fermentation assets while maintaining strain-specific efficacy data will continue to dominate a category where technical differentiation still commands meaningful premiums despite increasing commoditization pressure.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence